BeiGene

Mar 12, 2024

BeiGene’s BRUKINSA Gets FDA Accelerated Approval; GSK’s Positive Results in DREAMM-8 Phase III; Sandoz’s Denosumab Biosimilars FDA Approved; Terns Pharma’s TERN-701 Receives Orphan Drug Designation; Wegovy® Approved in US for Overweight Cardiovascular Risk; Travere Therapeutics Submits sNDA for FILSPARI IgAN Full Approval

Nov 05, 2019

AstraZeneca tops the first Pharma Invention Index; Amgen to buy 20.5% stake in a Chinese pharmaceutical, BeiGene; Ascentage, Henlius collaborates to develop a Combination therapy

Sep 04, 2019

Driving factors boosting the Hepatocellular Carcinoma Market

Aug 15, 2019

EU approval for Imbruvica; Pharming licenses orphan drug

Aug 17, 2018

KEY CLINICAL OUTCOMES

Mar 09, 2017

Business Cocktail

Newsletter/Whitepaper